Prevention of Rh Alloimmunization
References (63)
- et al.
Failures of intravenous Rh immune globulin prophylaxis: an analysis for the reasons of such failures
Transf Med Rev
(1987) - et al.
The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae
Lancet
(1983) - et al.
Hepatitis C viraemia in recipients of Irish intravenous anti-D immunoglobulin
Lancet
(1994) - et al.
Clinical high-risk designation does not predict excess fetal-maternal hemorrhage
Am J Obstet Gynecol
(1987) - et al.
Use of the erythrocyte rosette test to screen for excessive fetomaternal hemorrhage in Rh negative women
Am J Obstet Gynecol
(1986) The prevention of Rh immunization
Trans Med Review
(1988)- et al.
The incidence of significant fetomaternal haemorrhage in patients undergoing cesarean section
Am J Obstet Gynecol
(1990) - et al.
The role of Rh antibodies in haemolytic disease of the newborn
Baillieres Clin Haematol
(1993) - et al.
The cost of irregular antibody screening
Am J Obstet Gynecol
(1988) - et al.
Demonstration of Rh antigens in a 38-day-old fetus
Am J Obstet Gynecol
(1967)
The scientific basis of antenatal prophylaxis
Br J Obstet Gynaecol
(1998)
The decline of Rh hemolytic disease: should Rh prophylaxis get ail the credit?
Am J Public Health
(1998)
Antenatal prophylaxis of Rh isoimmunization: 28 weeks gestation service programme
Can Med Assoc J
(1978)
The Rh program of Nova Scotia 1964–1994;
(1995)
Canadian Task Force on the Periodic Health Exam
(1994)
Anti-D administration after childbirth for preventing Rhesus alioimmunization
The Cochrane Library (4)
(2001)
Experimental iso-immunization te hemo-antigens in man
J Immunol
(1961)
Use of Rh immune globulin. ASCP Practice Parameter
Am J Clin Pathol
(1998)
Prenatal Rh-immune globulin prophylaxis with 300 mcg immune globulin anti-D in the 28th week of pregnancy
Acta Obstet Gynecol Scand
(1989)
Maternai anti-D prophylaxis during pregnancy does not cause neonatal haemolysis
Arch Dis Child Fetal Neonatal Ed
(2001)
Safety profile of WINHRO Anti-D
Sem Hematol
(1998)
WinRho SDFTM Rh (D) immune globulin (human) passive immunizing agent
Irish mothers called for hepatitis C virus screening
Br J Med
(1994)
Rh isoimmunization during pregnancy: antenatal prophylaxis
Can Med Assoc J
(1978)
Preventing Rh sensitization during pregnancy
Perinat Care
(1978)
Effect on primary Rh immunization of delayed administration anti-Rh
Immunology
(1975)
Prevention of sensitization to Rh with anti-Rh gamma globulin
Fred Proc
(1964)
Antenatal suppression of Rh alloimmunization
Clin Obstet Gynecol
(1991)
Transplacental fetal haemorrhage after amniocentesis
Obstet Gynecol
(1985)
Fetomaternal hemorrhage: incidence, risk factors, time of occurrence and clinical effects
Transfusion
(1990)
Cited by (108)
-
Implementation of Low Titer Whole Blood for French overseas operations: O positive or negative products in massive hemorrhage?
2022, Transfusion Clinique et BiologiqueCitation Excerpt :In that situation, antibodies against red cell antigens are investigated and assessed before deployment. The prevalence of these anti-RhD antibodies in pregnant women is around 0.1% in France and could be around 0.05% in the general population [25,26]. Another key point is that, in the absence of existing alloimmunization, the minimum delay for the appearance of antibodies is at least one week.
-
Noninvasive Fetal RhD Blood Group Genotyping: A Systematic Review of Economic Evaluations
2021, Journal of Obstetrics and Gynaecology Canada -
Serologic strategy in detecting RHD altered alleles in Brazilian blood donors
2020, Hematology, Transfusion and Cell Therapy -
Very Prolonged Anti-D: Confusion Surrounding Alloimmunization After Extra Rh Immunoglobulin: A Case Report
2020, Journal of Obstetrics and Gynaecology Canada -
Alloimmunization in Pregnancy
2020, Immunologic Concepts in Transfusion Medicine -
Haemolytic Disease of the Fetus and Newborn
2019, Fetal Medicine: Basic Science and Clinical Practice
Copyright © 2003 Published by Elsevier Inc.